Skip to content
46

loperamide

Skip it

Strong incumbent ratings (4.7★) — this niche doesn't clear our bar today.

Market size 55Growth 30Conversion 100Competition 22Returns 100Price range 23Avg price 20Brand share 27Review moat 67Quality gap 20

Conversion

Incredible29.2%

search→purchase rate — share of searches ending in a sale

Returns

Incredible0.0%

return rate — above 5% kills the launch gate

Review moat

Good804.4

avg incumbent reviews — the moat a new listing must climb

Market size

Good£385K

£385K/yr · 184K searches

Growth

Okay+4.3%

90-day search growth — must beat 0% to launch

Brand share

Okay89%

top-5 brand share — brands hold most of the demand

Price range

Bad£3.31–£18.54

cheapest to priciest tracked listing — scored on the share inside $15–$100

Competition

Bad74%

top-5 click share — a locked-up shelf

Quality gap

Bad4.7★

avg incumbent rating — lower means beatable quality

Avg price

Bad£7.18

avg listing price — sweet spot $15–$100